In-Depth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,771
| Closed | -$4.81M | – | 14 |
|
|
2024
Q3 | $4.81M | Sell |
7,771
-3,089
| -28% | -$1.91M | 4.99% | 9 |
|
|
2024
Q2 | $6.01M | Sell |
10,860
-2,402
| -18% | -$1.33M | 5.53% | 10 |
|
|
2024
Q1 | $7.71M | Buy |
13,262
+356
| +3% | +$207K | 6.05% | 10 |
|
|
2023
Q4 | $6.85M | Hold |
12,906
| – | – | 5.98% | 10 |
|
|
2023
Q3 | $6.53M | Buy |
12,906
+1,505
| +13% | +$762K | 6.16% | 8 |
|
|
2023
Q2 | $5.95M | Sell |
11,401
-123
| -1% | -$64.2K | 6.22% | 9 |
|
|
2023
Q1 | $6.64M | Buy |
11,524
+2,050
| +22% | +$1.18M | 8.08% | 8 |
|
|
2022
Q4 | $5.22M | Hold |
9,474
| – | – | 9.51% | 5 |
|
|
2022
Q3 | $4.81M | Buy |
9,474
+514
| +6% | +$261K | 8.48% | 6 |
|
|
2022
Q2 | $4.87M | Sell |
8,960
-3,315
| -27% | -$1.8M | 8.89% | 5 |
|
|
2022
Q1 | $7.25M | Sell |
12,275
-4,670
| -28% | -$2.76M | 7.1% | 7 |
|
|
2021
Q4 | $11.3M | Buy |
+16,945
| New | +$11.3M | 6.87% | 7 |
|